IRIS
CIARDIELLO, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.486
AS - Asia 1.183
NA - Nord America 1.023
SA - Sud America 114
AF - Africa 13
Totale 4.819
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.909
US - Stati Uniti d'America 998
SG - Singapore 423
CN - Cina 260
IT - Italia 215
HK - Hong Kong 187
IE - Irlanda 152
VN - Vietnam 125
BR - Brasile 94
DE - Germania 79
KR - Corea 63
IN - India 48
GB - Regno Unito 33
JP - Giappone 25
FR - Francia 21
CA - Canada 16
FI - Finlandia 16
AT - Austria 14
PK - Pakistan 14
NL - Olanda 13
PL - Polonia 11
CZ - Repubblica Ceca 6
EC - Ecuador 6
MX - Messico 6
AR - Argentina 5
TR - Turchia 5
ID - Indonesia 4
IQ - Iraq 4
MA - Marocco 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
BD - Bangladesh 3
CO - Colombia 3
PH - Filippine 3
SE - Svezia 3
BO - Bolivia 2
CL - Cile 2
DO - Repubblica Dominicana 2
ES - Italia 2
GI - Gibilterra 2
GR - Grecia 2
JO - Giordania 2
KE - Kenya 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BE - Belgio 1
CH - Svizzera 1
CY - Cipro 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 4.819
Salva come PNG Salva come JPEG
Città #
Moscow 708
San Jose 230
Singapore 228
Hong Kong 182
Dublin 146
Santa Clara 128
Naples 80
Ashburn 77
Chandler 67
Seoul 62
Hefei 59
New York 47
Beijing 42
Ho Chi Minh City 41
Munich 40
Los Angeles 37
Dallas 33
Bengaluru 32
Hanoi 30
Haiphong 12
Bremen 11
Princeton 9
Rawalpindi 9
Roxbury 9
São Paulo 9
The Dalles 9
Turku 9
Warsaw 9
Da Nang 8
Cambridge 7
San Francisco 7
Vienna 7
Amsterdam 6
Changsha 6
Frankfurt am Main 6
London 6
Milan 6
Nuremberg 6
Atlanta 5
Aversa 5
Boardman 5
Giugliano in Campania 5
Lappeenranta 5
Manchester 5
Montreal 5
Orem 5
Piscataway 5
Brooklyn 4
Caserta 4
Chennai 4
Elora 4
Ercolano 4
Falkenstein 4
Hillsboro 4
Hải Dương 4
Mumbai 4
Shanghai 4
Tokyo 4
Baku 3
Bari 3
Battipaglia 3
Belo Horizonte 3
Berlin 3
Boston 3
Brno 3
Buffalo 3
Central 3
City of London 3
Colle di Val d'Elsa 3
Council Bluffs 3
Guayaquil 3
Istanbul 3
Montpellier 3
Nha Trang 3
Rio de Janeiro 3
San Diego 3
Sant'Antimo 3
Seattle 3
Shenzhen 3
Tianjin 3
Afragola 2
Amman 2
Anantapur 2
Andover 2
Anápolis 2
Baghdad 2
Bangkok 2
Barcellona Pozzo di Gotto 2
Bogotá 2
Bologna 2
Botucatu 2
Brdo 2
Bắc Giang 2
Campo Grande 2
Canoas 2
Castellammare di Stabia 2
Cercola 2
Chengdu 2
Chicago 2
Duque de Caxias 2
Totale 2.615
Salva come PNG Salva come JPEG
Nome #
Beyond N staging in colorectal cancer: Current approaches and future perspectives 223
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 183
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer 174
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial 162
Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR 161
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 161
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer 159
Real-world clinical outcome and safety of adjuvant therapy in stage III melanoma patients: Data from two Academic Italian Institutions 158
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials 154
Optimal treatment strategy for metastatic melanoma patients harboring BRAF-V600 mutations 151
CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCRC Patients 150
Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human BRAFV600E mutant colorectal cancer 150
Clinical management of metastatic colorectal cancer in the era of precision medicine 149
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 149
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 145
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial 145
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 144
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review 143
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) 141
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 139
Case report of unusual synchronous anal and rectal squamous cell carcinoma: clinical and therapeutic lesson 135
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 135
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial 132
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial 129
Identification of perineural invasion at imaging staging as a novel potential risk factor in rectal cancer: A case report 127
Immunotherapy in advanced anal cancer: Is the beginning of a new era? 127
Exploring biological heterogeneity and implications on novel treatment paradigm in BRAF-mutant metastatic colorectal cancer 125
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer 123
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 115
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 115
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941 115
Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM trial 113
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC 107
Targeting the EGFR signalling pathway in metastatic colorectal cancer 85
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer 29
MRI-based radiomics for preoperative T-staging of rectal cancer: a retrospective analysis 16
BRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectives 15
Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world study 3
Totale 4.887
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.861
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202268 0 2 1 1 5 0 0 0 2 3 30 24
2022/2023321 19 6 9 28 31 27 3 24 146 4 20 4
2023/2024226 22 8 8 14 47 48 7 5 8 6 21 32
2024/2025784 27 27 26 56 108 117 80 77 84 62 64 56
2025/20263.478 174 187 162 101 326 1.798 206 183 133 92 71 45
Totale 4.887